Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
50.99 USD | +0.97% |
|
+6.23% | +38.33% |
Jul. 09 | Goldman Sachs Raises Price Target on Twist Bioscience to $55 From $45, Maintains Buy Rating | MT |
Jul. 09 | Twist Bioscience Launches Synthetic RNA Control for H5N1 Influenza A | MT |
- Stock Market
- Equities
- TWST Stock
- News Twist Bioscience Corporation
- MarketScreener Strategies